ABPI have been denied the opportunity to legally challenge incorporation of the £20 million budget impact test being incorporated into NICE assessments.
Read the full article here
Learn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial ...
In a ground breaking move, the international collaboration among six prominent health technology ass...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.